Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2018 February;70(1) > Minerva Pediatrica 2018 February;70(1):107-9

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

 

LETTERS TO THE EDITOR   

Minerva Pediatrica 2018 February;70(1):107-9

DOI: 10.23736/S0026-4946.16.04778-2

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Teratogenicity of systemic isotretinoin

Helle HOLST 1, 2, Edit MUHARI-STARK 3, Sebastiano A. LAVA 4, 5, 6

1 Department of Clinical Pharmacology, Bispebjerg Hospital, Copenhagen, Denmark; 2 Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; 3 Medicines for Children Research Network (MCRN) Hungary, Budapest, Hungary; 4 University Children’s Hospital, Inselspital Bern, University of Bern, Bern, Switzerland; 5 Pediatric Pharmacology and Pharmacogenetics, Hôpital Robert Debré, Paris, France; 6 Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland


PDF


top of page